Argentina Blood Glucose Monitor Market Overview, 2028

Argentina, like many other countries, has an aging population. The elderly population is more prone to diabetes, and as the number of elderly individuals’ increases, so does the demand for blood glucose monitoring devices. The primary driver for the blood glucose monitoring devices market is the rising prevalence of diabetes. As the incidence of diabetes increases in Argentina, there is a growing demand for devices that help individuals monitor and manage their blood glucose levels effectively. According to the International Diabetes Federation, there are more than 33 million people with diabetes in the SACA region, which includes Argentina. Worldwide, there are 537 million people with diabetes. The Argentine government has taken steps to improve access to glucose monitoring devices for people with diabetes. In 2017, the government launched the Programa National de Diabetes, which provides free glucose meters and test strips to people with diabetes who are enrolled in the national healthcare system. Growing awareness among patients about the importance of regular blood glucose monitoring for diabetes management can drive the demand for monitoring devices. Patient education and awareness campaigns contribute to a proactive approach to healthcare. Cultural attitudes towards health and wellness can impact healthcare practices. If there is a cultural emphasis on preventive healthcare and self-management of chronic conditions, it can drive the adoption of blood glucose monitoring devices. The economic landscape of Argentina, including factors such as income levels and economic stability, can impact the affordability and accessibility of blood glucose monitoring devices. Economic growth and stability can contribute to increased healthcare spending and adoption of medical devices. According to the research report "Argentina Blood Glucose Monitoring Devices Market Overview, 2028," published by Bonafide Research, the Argentina Blood Glucose Monitoring Devices market is anticipated to grow at more than 7% CAGR from 2023 to 2028. The integration of blood glucose monitoring devices with digital health platforms, including mobile apps and electronic health records, is a global trend. In Argentina, the increasing adoption of digital health solutions could drive demand for devices that seamlessly integrate with these platforms for better data management and patient engagement. The COVID-19 pandemic has accelerated the adoption of telemedicine worldwide. In Argentina, the continuation of telehealth services may drive the demand for blood glucose monitoring devices that support remote monitoring, allowing healthcare professionals to track patients' glucose levels remotely. There is a growing emphasis on designing blood glucose monitoring devices that are user-friendly and accessible to a wide range of users. Devices with intuitive interfaces, simple operation, and features that cater to diverse user needs may gain popularity in Argentina. The integration of blood glucose monitoring into smart wearables, such as smartwatches and fitness trackers, is a growing trend. In Argentina, the popularity of smart devices may contribute to the adoption of wearable blood glucose monitoring solutions. Innovative payment models, such as subscription-based services or bundled offerings, can impact affordability and accessibility. In Argentina, solutions that cater to diverse economic segments may see increased adoption. Furthermore, the use of mobile health applications for diabetes management is expanding. Blood glucose monitoring devices that integrate with mHealth apps for tracking, analysis, and communication between patients and healthcare providers may see increased adoption.

In terms of product the market is divided into Self-monitoring Devices and Continuous Blood Glucose Monitoring Devices. Continuous blood glucose monitoring devices offer real-time data on glucose levels, providing a more comprehensive and immediate understanding of a person's glycemic profile. This real-time monitoring is valuable for individuals with diabetes, allowing for timely adjustments to treatment plans. Continuous monitoring devices typically provide more accurate and precise readings compared to traditional intermittent monitoring methods. This level of accuracy is crucial for effective diabetes management, as it helps individuals make informed decisions about their diet, medication, and lifestyle. Continuous glucose monitoring devices offer enhanced convenience compared to traditional fingerstick methods. They eliminate the need for frequent finger pricks, providing a more comfortable and less intrusive experience for individuals with diabetes. This improved convenience may contribute to higher patient adherence to monitoring routines. Continuous monitoring devices help reduce variability in glucose levels by providing a continuous stream of data throughout the day and night. This constant monitoring allows for a better understanding of how various factors, such as meals and physical activity, impact glucose levels, enabling more personalized and effective management. Many continuous glucose monitoring devices are designed to integrate with digital health platforms, including mobile apps and online portals. This integration enables users to track their glucose levels, receive insights, and share data with healthcare providers for remote monitoring and support. Based on end user the market is segmented into Hospitals, Home Care and Diagnostic Centers. Hospitals play a crucial role in the critical care and inpatient monitoring of diabetes cases, allowing healthcare professionals to closely observe and manage patients with acute fluctuations in blood glucose levels. This is essential for immediate intervention and ensuring the well-being of individuals with diabetes. The availability of advanced monitoring equipment in hospitals, including both traditional and continuous monitoring devices, contributes to accurate and reliable blood glucose readings. Professional oversight is a key advantage of the hospital setting, with healthcare professionals such as endocrinologists, nurses, and dietitians closely monitoring patients. This ensures precise data collection, interpretation, and the ability to make informed adjustments to treatment plans based on individual patient needs. Additionally, hospitals provide an environment with immediate access to emergency medical services, critical for addressing sudden and severe fluctuations in blood glucose levels. Outpatient clinics within hospitals further enhance their role as a centralized location for ongoing diabetes care. Patients can visit these clinics for regular check-ups, monitoring, and consultations, contributing to the convenience of healthcare services. Hospitals also offer training and education to both healthcare professionals and patients, ensuring proper guidance on the effective use of blood glucose monitoring devices and understanding the significance of monitoring results. Considered in this report: • Geography: Argentina • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028 Aspects covered in this report: • Argentina Blood Glucose Monitoring Devices market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product • Self-monitoring Devices • Continuous Blood Glucose Monitoring Devices By End User • Hospitals • Home Care • Diagnostic Centers

By Indication • Diabetes • Pregnancy • Cardiovascular Disorders & Hypertension • Cancer • Respiratory Diseases • Movement Disorders • Hearing Disorders • Wound Care • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Blood Glucose Monitoring Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.